General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-01 | 2024-03 | -0.04 | -0.01 | 0.03 | 75.00% |
2024-02-29 | 2023-12 | -0.04 | N/A | N/A | N/A |
2023-11-01 | 2023-09 | -0.02 | N/A | N/A | N/A |
2023-08-02 | 2023-06 | -0.02 | 0.02 | 0.04 | 200.00% |
2023-05-03 | 2023-03 | -0.01 | 0.02 | 0.03 | 300.00% |
2023-03-01 | 2022-12 | 0.01 | 0.02 | 0.01 | 100.00% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-07-19 | Goldman Sachs | Upgrade | Sell | Sell |
2023-07-18 | Northland Capital Markets | Upgrade | Market Perform | Market Perform |
2023-01-05 | Jefferies | Upgrade | Hold | Buy |
2022-10-18 | SVB Leerink | Upgrade | Market Perform | |
2022-05-23 | Goldman Sachs | Upgrade | Sell | |
2022-05-05 | JP Morgan | Downgrade | Neutral | Underweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-01-30 | BERG AARON D. | Officer | 633.26K | Conversion of Exercise of derivative security |
2024-01-21 | HOLT PATRICK | Chief Executive Officer | 314.43K | Purchase |
2022-07-28 | KALB MICHAEL WAYNE | Chief Financial Officer | 337.31K | Conversion of Exercise of derivative security |
2024-01-30 | KETCHUM STEVEN B | Officer | 658.72K | Conversion of Exercise of derivative security |
2022-08-18 | MARKS JASON M | Officer | 21.92K | Conversion of Exercise of derivative security |
2023-02-20 | MIKHAIL KARIM | Chief Executive Officer | 283.51K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Kynam Capital Management, LP | 12.00M | 14.28M | 12.15% |
2023-06-29 | Morgan Stanley | 11.28M | 13.42M | 11.41% |
2023-06-29 | Eversept Partners, LP | 10.50M | 12.50M | 10.63% |
2023-06-29 | Tang Capital Management, LLC | 7.10M | 8.45M | 7.19% |
2023-06-29 | SCP Investment, LP | 6.50M | 7.74M | 6.58% |
2023-06-29 | DG Capital Management, LLC | 5.47M | 6.51M | 5.54% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Northern Lights Fd Tr-13D Activist Fd | 3.81M | 4.53M | 3.85% |
2023-06-29 | Mutual Fund Ser Tr-AlphaCentric LifeSci Healthcare Fund | 585.00K | 696.15K | 0.59% |
2023-06-29 | Legg Mason Clearbridge Small Cap Value Fd | 531.07K | 631.97K | 0.54% |
2023-06-29 | Columbia Fds Var Ser Tr II-Columbia Var Port-Overseas Core Fd | 458.93K | 546.12K | 0.46% |
2023-05-30 | Columbia Fds Ser Tr-Columbia Overseas Value Fd | 315.88K | 369.58K | 0.32% |
2023-05-30 | Fidelity NASDAQ Composite Index Fund | 214.39K | 250.83K | 0.22% |
Split | Date |
---|---|
0.1 : 1 | 2008-01-18 |
0.1 : 1 | 1998-10-19 |
Can someone educate me please? If AGN was worth $60B in a buyout then what should Amarin be worth with Vascepa?
Does anyone on this board actually have a career in the biomed industry or directly with the FDA? If not, do all of these posts even matter?
Moron bears - why ask the question about Adcom and open that can of worms? Don’t ask don’t tell
Why do all the longs look at the drops as a bad thing. We all know it’s getting a BO. Just buy more.
The phrase “cant we all just get along” applies here. Bears are making a killing while this stock is being heavily manipulated and longs will make a killing once this is bought out. All rainbows and unicorns
I’m long but want to buy more. Hope it dips under $17. Loading up
$AMRN Wall Street Journal on the rise of heart attack’s in younger people
https://apple.news/AsBFzI0b_SoKRyz8O9VlVYg
A message for the Bears in 9/28
Without Jordan and Frank this board would be boring. Whoever is paying you guys to act like bears and spread doom & gloom is not paying you both enough.
Insider selling has never effected this stock - no matter how loud the bears say it.
So.....does Amarin get a BO before the market crashes?
https://apple.news/AiXZHjnHoQF-cVVKRcXfQvA
$32PPS BO price is too low. $32pps / $4.7 (Array BO) = $6.8B which is basically close to what Amarin is now.
Maybe there already is a deal in place. Accepted purchase price once label expansion approval
Typical Monday coming folks. MM really stands for “Master Manipulators”
Array - $11.4B buyout / $48 pps = $4.7. A buyout of Amarin at $15B x $4.7 = $70.50 pps. I would imagine Amarin has to be worth more than Array with a blockbuster, unicorn drug which will change the market
Jordan asking his mom for dinner tonight
Let’s try this again (fat fingers and autocorrect don’t mix). Did anyone notice Baker Bros are almost $900m invested in Amarin? Can anyone confirm?
Did anyone notice Baker. RCOs is almost at 900m shares?
All - this stock isn’t going anywhere until Sept.